Catalyst Wire Dossier Catalyst Wire Dossier

FP-1201-lyo

Interferon Beta-1a · Faron Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FP-1201-lyo, covering 2020-03-30 to 2021-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA [Phase 2]

See pricing